Bayer Aktiengesellschaft (BAYN)

Basic

  • Market Cap

    €27.83B

  • EV

    €66.12B

  • Shares Out

    982.42M

  • Revenue

    €47.78B

  • Employees

    100,873

Margins

  • Gross

    60.13%

  • EBITDA

    20.69%

  • Operating

    4.11%

  • Pre-Tax

    -5.01%

  • Net

    -7.68%

  • FCF

    -1.06%

Returns (5Yr Avg)

  • ROA

    3.65%

  • ROTA

    -0.94%

  • ROE

    0.12%

  • ROCE

    7.68%

  • ROIC

    5.04%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €42.45

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €9,306M

  • Net Debt

    €38.12B

  • Debt/Equity

    1.41

  • EBIT/Interest

    1.8

Growth (CAGR)

  • Rev 3Yr

    4.26%

  • Rev 5Yr

    6.43%

  • Rev 10Yr

    1.76%

  • Dil EPS 3Yr

    -38.76%

  • Dil EPS 5Yr

    -10.73%

  • Dil EPS 10Yr

    -0.02%

  • Rev Fwd 2Yr

    -2.61%

  • EBITDA Fwd 2Yr

    -9.62%

  • EPS Fwd 2Yr

    -14.05%

  • EPS LT Growth Est

    -1.86%

Dividends

  • Yield

  • Payout

    -64.3%

  • DPS

    €2.4

  • DPS Growth 3Yr

    -5.01%

  • DPS Growth 5Yr

    -3.04%

  • DPS Growth 10Yr

    2.36%

  • DPS Growth Fwd 2Yr

    -3.51%

Select a metric from the list below to chart it

Dec '13

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

LTM

Total Revenues

36,742

43,545

41,400

44,081

50,739

47,775

Total Revenues % Chg.

4.9%

18.5%

-4.9%

6.5%

15.1%

-4.2%

Cost of Goods Sold, Total

13,069

16,423

15,727

17,045

18,886

19,046

Gross Profit

23,673

27,122

25,673

27,036

31,853

28,729

Selling General & Admin Expenses, Total

13,238

14,801

13,886

14,531

16,036

14,881

R&D Expenses

4,701

5,282

4,884

5,326

6,168

5,511

Other Operating Expenses

1,477

59

-69

-296

528

6,373

Other Operating Expenses, Total

19,416

20,142

18,701

19,561

22,732

26,765

Operating Income

4,257

6,980

6,972

7,475

9,121

1,964

Interest Expense, Total

-1,401

-1,689

-1,500

-930

-1,058

-1,094

Interest And Investment Income

319

294

202

346

379

379

Net Interest Expenses

-1,082

-1,395

-1,298

-584

-679

-715

Income (Loss) On Equity Invest.

68

160

-96

49

-150

-169

Currency Exchange Gains (Loss)

-137

58

-216

-385

-219

-285

Other Non Operating Income (Expenses)

153

-3

102

-384

-844

-699

EBT, Excl. Unusual Items

3,259

5,800

5,464

6,171

7,229

96

Restructuring Charges

Merger & Related Restructuring Charges

-124

Impairment of Goodwill

-208

-2,238

-734

-734

Gain (Loss) On Sale Of Investments

-155

30

541

-3

-450

-382

Gain (Loss) On Sale Of Assets

-132

Asset Writedown

4,277

439

126

218

1,691

1,691

Insurance Settlements

Legal Settlements

-677

-546

-13,330

-3,689

-791

-791

Other Unusual Items

-4,562

-2,662

-7,813

-651

-2,275

-2,275

EBT, Incl. Unusual Items

1,886

2,853

-17,250

2,046

4,670

-2,395

Income Tax Expense

496

443

-1,689

1,024

504

1,280

Earnings From Continuing Operations

1,390

2,410

-15,561

1,022

4,166

-3,675

Earnings Of Discontinued Operations

321

1,700

5,074

Minority Interest

-16

-19

-8

-22

-16

8

Net Income

1,695

4,091

-10,495

1,000

4,150

-3,667

Net Income to Common Incl Extra Items

1,695

4,091

-10,495

1,000

4,150

-3,667

Net Income to Common Excl. Extra Items

1,374

2,391

-15,569

1,000

4,150

-3,667

Total Shares Outstanding

932.6

982.4

982.4

982.4

982.4

982.4

Weighted Avg. Shares Outstanding

940.8

981.7

982.4

982.4

982.4

982.4

Weighted Avg. Shares Outstanding Dil

940.8

981.7

982.4

982.4

982.4

982.4

EPS

1.8

4.2

-10.7

1

4.2

-3.7

EPS Diluted

1.8

4.2

-10.7

1

4.2

-3.7

EBITDA

7,145

10,810

10,030

10,877

12,705

9,886